Title |
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group
|
---|---|
Published in |
Annals of Hematology, October 2019
|
DOI | 10.1007/s00277-019-03815-7 |
Pubmed ID | |
Authors |
Sini Luoma, Pekka Anttila, Marjaana Säily, Tuija Lundan, Jouni Heiskanen, Timo Siitonen, Sakari Kakko, Mervi Putkonen, Hanna Ollikainen, Venla Terävä, Marja Sankelo, Anu Partanen, Kirsi Launonen, Anu Räsänen, Anu Sikiö, Merja Suominen, Piotr Bazia, Kristiina Kananen, Juha Lievonen, Tuomas Selander, Tarja-Terttu Pelliniemi, Sorella Ilveskero, Virva Huotari, Pentti Mäntymaa, Anri Tienhaara, Esa Jantunen, Raija Silvennoinen |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Algeria | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 37 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 6 | 16% |
Student > Bachelor | 5 | 14% |
Student > Master | 5 | 14% |
Researcher | 4 | 11% |
Student > Ph. D. Student | 2 | 5% |
Other | 2 | 5% |
Unknown | 13 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 32% |
Nursing and Health Professions | 3 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Business, Management and Accounting | 1 | 3% |
Other | 2 | 5% |
Unknown | 15 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2019.
All research outputs
#17,932,284
of 25,837,817 outputs
Outputs from Annals of Hematology
#1,373
of 2,454 outputs
Outputs of similar age
#244,040
of 380,453 outputs
Outputs of similar age from Annals of Hematology
#18
of 50 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,454 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,453 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.